Maria Shatz, Ph.D.

2007 BIR Biological Regulation Weizmann Institute of Science, Rehovot, Israel 
Molecular Biology
"Maria Shatz"


Sign in to add mentor
Mordechai Liscovitch grad student 2007 Weizmann Institute
 (Caveolin-1: Role in cancer cell survival, migration and invasiveness.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shatz M, Shats I, Menendez D, et al. (2015) p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways. Oncotarget. 6: 16963-80
Lowe JM, Menendez D, Bushel PR, et al. (2014) p53 and NF-κB coregulate proinflammatory gene responses in human macrophages. Cancer Research. 74: 2182-92
Madenspacher JH, Azzam KM, Gowdy KM, et al. (2013) p53 Integrates host defense and cell fate during bacterial pneumonia. The Journal of Experimental Medicine. 210: 891-904
Menendez D, Shatz M, Resnick MA. (2013) Interactions between the tumor suppressor p53 and immune responses. Current Opinion in Oncology. 25: 85-92
Shatz M, Menendez D, Resnick MA. (2012) The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells. Cancer Research. 72: 3948-57
Menendez D, Shatz M, Azzam K, et al. (2011) The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. Plos Genetics. 7: e1001360
Shatz M, Lustig G, Reich R, et al. (2010) Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells. Experimental Cell Research. 316: 1748-62
Shatz M, Liscovitch M. (2008) Caveolin-1: a tumor-promoting role in human cancer. International Journal of Radiation Biology. 84: 177-89
Burgermeister E, Xing X, Röcken C, et al. (2007) Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Research. 67: 8519-26
Milyavsky M, Shats I, Cholostoy A, et al. (2007) Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect. Cancer Cell. 11: 133-46
See more...